FDA approves Zepbound for obstructive sleep apnea in obese individuals Discover how this weight-loss drug reduces symptoms ...
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
Key Takeaways Eli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with ...
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating ...
Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...